Product Information
DAPTOMYCIN 350 MG VIAL is a generic product labeled by Xellia Pharmaceuticals USA LLC, priced at $13.4180 per EA under NDC 70594005301. Its NADAC has been published 83 times since Dec 18, 2024.
FDA first approved this application on Oct 20, 2017.
Strength
350 mg/7mL
Manufacturer
Xellia Pharmaceuticals USA LLCNDC
70594005301
Classification
Generic
Dosage Form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS
Effective Date
7/23/2025
Active Ingredients
DAPTOMYCINApproval Type
New Drug (NDA)
FDA Application
NDA209949FDA Approved
10/20/2017
On Market Since
3/15/2019
Pharmacological Classes
Price Statistics
The NADAC for DAPTOMYCIN 350 MG VIAL has been published 83 times since Dec 18, 2024, and over the history we have for it it has declined 25.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $13.4180 per EA |
|---|---|
| All-time high | $17.9420 (Apr 16, 2025) |
| All-time low | $13.3620 (Apr 23, 2025) |
| 52-week high | $13.4180 |
| 52-week low | $13.4180 |
| Median price | $13.4180 |
| Average price | $14.3934 |
| Largest weekly change | -25.5% (Apr 23, 2025) |
| Weeks tracked | 83 |
| Tracking since | Dec 18, 2024 |
1W
N/A
1M
N/A
3M
0.0%
6M
0.0%
1Y
0.0%
3Y
N/A
5Y
N/A
All
-25.2%
Last surveyed Jul 15, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of DAPTOMYCIN 350 MG VIAL?
The current National Average Drug Acquisition Cost (NADAC) for DAPTOMYCIN 350 MG VIAL, manufactured by Xellia Pharmaceuticals USA LLC, is $13.4180 per EA (NDC 70594005301), effective Jul 15, 2026.
How has the price of DAPTOMYCIN 350 MG VIAL changed over time?
Over the history we have for it, the NADAC for DAPTOMYCIN 350 MG VIAL has declined 25.2%. It has been tracked across 83 weekly CMS publications since Dec 18, 2024.
What are the highest and lowest recorded NADAC prices for DAPTOMYCIN 350 MG VIAL?
Since Dec 18, 2024, the NADAC for DAPTOMYCIN 350 MG VIAL has ranged from a low of $13.3620 (Apr 23, 2025) to a high of $17.9420 (Apr 16, 2025), with a median of $13.4180 per EA.
Are there cheaper alternatives to DAPTOMYCIN 350 MG VIAL?
6 manufacturers publish a NADAC-priced product with the same active ingredient and strength as DAPTOMYCIN 350 MG VIAL in a comparable dosage form, but none are currently priced below it.
Who manufactures DAPTOMYCIN 350 MG VIAL?
DAPTOMYCIN 350 MG VIAL (NDC 70594005301) is labeled by Xellia Pharmaceuticals USA LLC, and CMS classifies it as a generic product.